NCT01245972

Brief Summary

This is a research study to find out more about the use of the pulsed dye laser in the treatment of basal cell carcinoma and early stage squamous cell carcinoma that has not invaded deep into the skin. The purpose of this study is to determine whether the use of the pulsed dye laser (PDL) can completely clear or regress basal cell carcinoma or early stage squamous cell carcinoma. Pulsed dye laser is a type of laser that is commonly used to treat lesions on the skin that have a prominent blood vessel component. It has been used to treat broken blood vessels on the face, hemangiomas in children and adults, leg veins, port wine stains, and other lesions with a prominent vascular component.

Trial Health

100
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
23

participants targeted

Target at below P25 for not_applicable

Timeline
Completed

Started Aug 2010

Shorter than P25 for not_applicable

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

August 1, 2010

Completed
4 months until next milestone

First Submitted

Initial submission to the registry

November 22, 2010

Completed
1 day until next milestone

First Posted

Study publicly available on registry

November 23, 2010

Completed
6 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 1, 2011

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2011

Completed
8.3 years until next milestone

Results Posted

Study results publicly available

September 16, 2019

Completed
Last Updated

September 16, 2019

Status Verified

August 1, 2019

Enrollment Period

10 months

First QC Date

November 22, 2010

Results QC Date

July 3, 2019

Last Update Submit

August 14, 2019

Conditions

Keywords

pulsed dye laserPDLbasal cell carcinomasquamous cell carcinomaBCCSCC594nM laser

Outcome Measures

Primary Outcomes (1)

  • Tumor Clearance

    Review of the pathology report showing whether there was residual tumor or not. If there was no residual tumor in the pathology report from the confirmatory excision, the laser treatment was considered successful (tumor clearance).

    21 to 36 days after the treatment

Study Arms (3)

Control

NO INTERVENTION

No treatment administered

PDL Setting 1

EXPERIMENTAL

PDL Setting 1: 15 J/cm2, 3ms pulse length, no dynamic cooling, 7mm spot size, 10% overlap between the pulses, 2 passes

Procedure: PDL Treatment

PDL Setting 2

EXPERIMENTAL

PDL Setting 2: 7.5 J/cm2, 3ms pulse length, no dynamic cooling, 10mm spot size, 10% overlap between the pulses, 2 stacked pulses

Procedure: PDL Treatment

Interventions

PDL TreatmentPROCEDURE

Pulsed-dye laser (PDL) treatment at one of two settings.

PDL Setting 1PDL Setting 2

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Patients requiring surgical excision (conventional or Mohs) for biopsy-proven basal cell carcinoma and biopsy-proven squamous cell carcinoma in situ that is clinically present at the pre-operative visit and measures greater than 0.4cm and less than 3cm in size.
  • Lesions in the Trunk, Extremities, and Scalp
  • Presence of clinically identifiable residual tumor.
  • Patients, males and females, aged 18-90 years.
  • Willing to participate.
  • Able to give informed consent.

You may not qualify if:

  • Age younger than 18 years
  • Location of lesion not in the Trunk, Extremities, and Scalp
  • Fitzpatrick skin type V or VI.
  • Prior history of known light sensitivity.
  • Pregnancy
  • Cognitive Impairment
  • Prisoner

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, Basal CellSquamous Intraepithelial LesionsCarcinoma, Squamous Cell

Condition Hierarchy (Ancestors)

CarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsNeoplasms, Basal CellMorphological and Microscopic FindingsPathological Conditions, Signs and SymptomsNeoplasms, Squamous Cell

Results Point of Contact

Title
S. Brian Jiang
Organization
ucsdmed

Study Officials

  • S. I. Brian Jiang, MD

    UCSD Medical Center, Division of Dermatology

    PRINCIPAL INVESTIGATOR

Publication Agreements

PI is Sponsor Employee
No
Restrictive Agreement
No

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Clinical Professor of Dermatology

Study Record Dates

First Submitted

November 22, 2010

First Posted

November 23, 2010

Study Start

August 1, 2010

Primary Completion

June 1, 2011

Study Completion

June 1, 2011

Last Updated

September 16, 2019

Results First Posted

September 16, 2019

Record last verified: 2019-08